home > drugs a-z list > omniscan (gadodiamide) drug center > omniscan (gadodiamide) drug - overdosage and contraindications

Clinical consequences of overdose with OMNISCAN (gadodiamide) have not been reported. The minimum lethal dose of intravenously administered OMNISCAN (gadodiamide) in rats and mice is greater than 20 mmol/kg (200 times the recommended human dose of 0.1 mmol/kg; 67 times the cumulative 0.3 mmol/kg dose). OMNISCAN (gadodiamide) is dialyzable.

OMNISCAN (gadodiamide) is contraindicated in patients with:

• chronic, severe kidney disease (glomerular filtration rate, GFR < 30 mL/min/1.73m²), or
• acute kidney injury.

Last reviewed on RxList: 2/11/2011
This monograph has been modified to include the generic and brand name in many instances.